查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045980

助劑市場－全球產業規模、佔有率、趨勢、機會和預測：按產品類型、應用、最終用戶、地區和競爭格局分類，2021-2031年

Ancillary Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球輔助試劑市場預計將從 2025 年的 113.8 億美元大幅成長至 2031 年的 173.8 億美元，複合年成長率為 7.31%。

該市場涵蓋細胞激素、酵素和緩衝液等關鍵原料，這些原料對於細胞療法和基因療法的生產至關重要，但並非最終產品中的成分。成長要素包括生物製藥開發平臺的快速擴張（目前有超過3000種治療方法正在研發中）以及先進治療方法從臨床研究轉向商業化生產的轉變。這需要穩定供應符合法規要求的GMP級試劑。然而，阻礙市場進一步擴張的一個主要挑戰是缺乏統一的全球原料監管標準。這導致供應鏈複雜化，並增加了在不同司法管轄區運營的製造商的合規負擔。

市場概覽
預測期 2027-2031
市場規模：2025年 113.8億美元
市場規模：2031年 173.8億美元
複合年成長率：2026-2031年 7.31%
成長最快的細分市場 臨床診斷
最大的市場 北美洲

市場促進因素

細胞和基因治療領域的快速發展是輔助試劑市場的主要驅動力，該領域需要專門的GMP級試劑用於細胞分離、活化和增殖等製程。此外，超過3200種治療方法正在推進臨床試驗，這進一步推動了試劑需求，需要可擴展且穩定的試劑供應以滿足嚴格的安全標準。同時，全球生物製藥和生物相似藥產量的激增也加速了市場發展，推動了大規模商業生產中對高品質緩衝液和製程耗材的需求。隨著製造商擴大產能和新藥核准，依賴經過驗證的輔助材料對於確保批次間一致性和符合法規要求至關重要。

市場挑戰

全球輔助試劑市場成長面臨的主要障礙是缺乏統一的原料監管標準。隨著生物製藥研發公司日益國際化運營，缺乏統一的法規結構迫使試劑供應商在不同司法管轄區遵守不同的合規要求。這種監管碎片化顯著增加了供應鏈的複雜性，因為在一個地區符合標準的材料在另一個地區可能需要額外的驗證和文件。因此，製造商必須投入大量資金和技術資源用於重複的合規活動，從而增加營運成本並延長關鍵原料的前置作業時間。隨著產業從臨床開發轉向商業化生產，這一瓶頸尤為嚴重，阻礙了市場高效滿足對高品質原料激增的需求。

市場趨勢

目前，兩大關鍵趨勢正在改變輔助試劑的市場結構。首先，為消除細胞和基因療法生產中的污染風險並最大限度地減少人為錯誤，自動化和封閉式生產流程的整合勢在必行。這一趨勢要求試劑必須與先進的加工設備和機器人平台相容，以確保無縫擴充性和批次間一致性，因此許多生命科學專業人士將數位化和自動化列為資本投資的優先考慮。其次，人們越來越關注永續和環保的試劑生產方法，這迫使供應商透過減少一次性塑膠的使用和採用碳中和生產等措施來降低其對環境的影響。隨著生物製藥公司經營團隊日益將缺乏永續性視為一項重大的組織風險，向更環保的供應鏈轉型以及遵守環境、社會和管治(ESG) 要求對於企業的長期生存和市場競爭力至關重要。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球助劑市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（緩衝液、稀釋劑、溶劑、酵素、染色劑/染料、其他）
    • 按應用領域（臨床診斷、藥物發現與開發、免疫學、分子生物學、基因組學和蛋白​​質組學、微生物學等）
    • 依最終用戶（醫院/診斷檢查室、製藥/生技公司、研究機構、受託研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美輔助試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲助試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區輔助試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲助試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲助劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球助劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Promega Corporation
  • Sartorius AG
  • Miltenyi Biotec BV & Co. KG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27634

The Global Ancillary Reagents Market is projected to expand significantly, rising from USD 11.38 Billion in 2025 to USD 17.38 Billion by 2031, demonstrating a 7.31% CAGR. This market encompasses essential raw materials like cytokines, enzymes, and buffers, which are critical for the manufacturing of cell and gene therapies but are not intended to remain in the final product. The primary drivers include the rapid expansion of the biopharmaceutical development pipeline, with over 3,000 therapies currently in development, and the transition of advanced therapies from clinical research to commercial production, necessitating consistent supplies of compliant, GMP-grade reagents. However, a significant challenge impeding broader market expansion is the lack of harmonized global regulatory standards for raw materials, leading to complex supply chains and compliance burdens for manufacturers operating across different jurisdictions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.38 Billion
Market Size 2031USD 17.38 Billion
CAGR 2026-20317.31%
Fastest Growing SegmentClinical Diagnostics
Largest MarketNorth America

Market Driver

The exponential growth of the cell and gene therapy sector is the primary catalyst for the ancillary reagents market, demanding specialized, GMP-grade inputs for processes like cell isolation, activation, and expansion. This demand is intensified by a robust pipeline of over 3,200 therapies progressing through clinical phases, requiring scalable and consistent reagent supplies to meet strict safety standards. Furthermore, surging global production of biopharmaceuticals and biosimilars accelerates market momentum, driving the need for high-quality buffer solutions and process consumables in large-scale commercial manufacturing. As manufacturers expand capacity and new drugs gain approval, the reliance on validated ancillary materials becomes critical to ensure batch consistency and regulatory compliance.

Market Challenge

The lack of harmonized global regulatory standards for raw materials presents a significant impediment to the growth of the Global Ancillary Reagents Market. As biopharmaceutical developers increasingly operate internationally, the absence of a unified regulatory framework forces reagent suppliers to navigate disparate compliance requirements across various jurisdictions. This regulatory fragmentation creates substantial supply chain complexities, as materials compliant in one region may require additional validation or documentation elsewhere. Consequently, manufacturers must dedicate considerable capital and technical resources to redundant compliance activities, which increases operational costs and extends lead times for critical inputs. This bottleneck is particularly acute as the industry scales from clinical development to commercial production, hindering the market's ability to efficiently meet surging demand for high-grade materials.

Market Trends

Two pivotal trends are currently reshaping the ancillary reagents landscape. Firstly, there is a growing integration with automated and closed-system manufacturing workflows, driven by the imperative to eliminate contamination risks and minimize human error in cell and gene therapy production. This trend necessitates reagents compatible with advanced processing equipment and robotic platforms to ensure seamless scalability and enhance batch consistency, with many life sciences professionals prioritizing digitalization and automation in their capital investments. Secondly, a pronounced focus on sustainable and eco-friendly reagent production practices is emerging, compelling suppliers to reduce their environmental footprint through initiatives like cutting single-use plastics and adopting carbon-neutral manufacturing. This shift towards greener supply chains and adherence to environmental, social, and governance (ESG) mandates is becoming critical for long-term viability and market competitiveness, as biopharma executives increasingly view sustainability failures as a significant organizational risk.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Promega Corporation
  • Sartorius AG
  • Miltenyi Biotec B.V. & Co. KG

Report Scope

In this report, the Global Ancillary Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ancillary Reagents Market, By Product Type

  • Buffers
  • Diluents
  • Solvents
  • Enzymes
  • Stains & Dyes
  • Others

Ancillary Reagents Market, By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Immunology
  • Molecular Biology
  • Genomics & Proteomics
  • Microbiology
  • Others

Ancillary Reagents Market, By End User

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Research Institutions
  • Contract Research Organizations
  • Others

Ancillary Reagents Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ancillary Reagents Market.

Available Customizations:

Global Ancillary Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ancillary Reagents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Buffers, Diluents, Solvents, Enzymes, Stains & Dyes, Others)
    • 5.2.2. By Application (Clinical Diagnostics, Drug Discovery & Development, Immunology, Molecular Biology, Genomics & Proteomics, Microbiology, Others)
    • 5.2.3. By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutions, Contract Research Organizations, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ancillary Reagents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ancillary Reagents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Ancillary Reagents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Ancillary Reagents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Ancillary Reagents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ancillary Reagents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Ancillary Reagents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Ancillary Reagents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Ancillary Reagents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Ancillary Reagents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Ancillary Reagents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ancillary Reagents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Ancillary Reagents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Ancillary Reagents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Ancillary Reagents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Ancillary Reagents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Ancillary Reagents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ancillary Reagents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Ancillary Reagents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Ancillary Reagents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Ancillary Reagents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ancillary Reagents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Ancillary Reagents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Ancillary Reagents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ancillary Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. Lonza Group Ltd.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Agilent Technologies, Inc.
  • 15.6. PerkinElmer, Inc.
  • 15.7. Qiagen N.V.
  • 15.8. Promega Corporation
  • 15.9. Sartorius AG
  • 15.10. Miltenyi Biotec B.V. & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer